தேசிய நிறுவனம் க்கு மருத்துவ சிறப்பானது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய நிறுவனம் க்கு மருத்துவ சிறப்பானது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய நிறுவனம் க்கு மருத்துவ சிறப்பானது Today - Breaking & Trending Today

New research into treatment and diagnosis of long COVID


New research into treatment and diagnosis of long COVID
15 new studies across the UK will expand research into long COVID to support thousands of vulnerable people, backed by nearly £20 million through the NIHR
From:
15 new studies across UK to expand research that will support thousands of vulnerable people
Nearly £20 million for research projects will help improve understanding of long COVID and identify effective treatments
Projects include the largest long COVID trial to date which will involve over 4,500 people
Thousands of people suffering with long COVID will benefit from new research programmes backed by £19.6 million to help better understand the condition, improve diagnosis and find new treatments. ....

United Kingdom , City Of , Manoj Sivan , Nicholas Sculthorpe , Wales Simon Hart , Sajid Javid , Amitava Bannerjee , Daniel Altmann , Iain Stewart , Amitava Banerjee , Mark Baker , Nick Lemoine , Dennis Chan , Tim Nicholson , Wrexham Wockhardt , Fergus Gleeson , Fiona Jones , David Blane , Daniel Prieto Alhambra , King College London , University College London , Cardiff University , Newcastle University , University Of Cambridge , University College Of London , National Institute For Clinical Excellence ,

Khiron Comments on the Results of Project Twenty21 - UK's Largest Observational Study into Medical Cannabis Products


(1)
Khiron is a founding member of Project Twenty 21 and was the first supplier of EU-GMP high-THC dried cannabis flower to the study
The findings show that medical Cannabis dramatically improves quality of life for people with life-limiting conditions, including Chronic Pain, Multiple Sclerosis, Tourette s Syndrome and PTSD
Legal prescriptions allow patients to access medical cannabis without engaging in criminality and to avoid dependency associated with other medicines commonly prescribed for these debilitating conditions
TORONTO, May 11, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal Psychopharmacology of the first findings arising from Project Twenty 21, UK s first and largest national medical cannabis registry that was launch ....

United Kingdom , United States , City Of , Paola Ricardo , Khiron Europe , David Nutt , Alvaro Torres , Tejinder Virk , Cannabis Clinicians Society , Khiron Academy , Europe Communications , National Institute For Clinical Excellence , Prnewswire Khiron Life Sciences Corp , Khiron Life Sciences Corp , Regulation Services Provider , Royal College Of Psychiatrists , Project Twenty , Chronic Pain , Multiple Sclerosis , Life Sciences , Latin America , Royal College , Drug Science , Post Traumatic Stress Disorder , Project Twety , National Institute ,